KRAS and non-small cell lung carcinoma: Transcriptomic analyses revealed significant overexpression of EGFR (2.8-fold), KRAS (2.3-fold), ALK (1.9-fold), and PDCD1 (2.1-fold) in NSCLC tissues (p < 0.01).